ORAL TIRZEPATIDE TABLETS
- Regular price
-
$339 - Regular price
-
$0 - Sale price
-
$339
Pricing is for a monthly supply (4 weeks). Prescription medication. Medical evaluation required.
What it is
Tirzepatide made simple: a daily oral tablet, no injections. Provider-prescribed GLP-1 support for your weight goals, shipped to your door by Fitish RX. Tirzepatide activates two appetite and metabolism regulating pathways: GLP-1 to slow digestion and reduce hunger, and GIP to support insulin response and energy use.
At Fitish RX, tirzepatide pills are a daily oral tablet taken by mouth, a needle-free alternative to the once-weekly injection.
For patients who prefer to skip injections, who travel often, dislike needles, or want a more discreet routine, the oral tablet form provides a daily dosing option with the same active mechanism. Taken once daily, ideally on an empty stomach with a small amount of water.
Prefer the standard once-weekly injection? See our compounded tirzepatide program.
Benefits patients commonly report
- Reduced appetite and food noise
- Steady, sustainable weight management when paired with diet and movement
- Improved insulin sensitivity and glucose stability
- No injections required
- Predictable daily routine that integrates easily into travel, work, and life
A note on whole body wellness
A more steady appetite, better hydration, and the lifestyle changes that often come with this protocol can show up in skin clarity, sleep quality, and overall energy.
What to expect
Appetite shifts typically begin within the first 1 to 2 weeks. Weight progress usually becomes visible over 8 to 16 weeks of consistent daily use. Oral tirzepatide may take slightly longer to reach peak effect than injectable forms. Side effects, when they occur, are usually mild gastrointestinal symptoms that ease over time.
Who it's for
Adults pursuing medical weight management who prefer an oral option and meet clinical eligibility criteria. A licensed provider reviews every intake.
Important to know
Compounded oral tirzepatide is prepared by a state licensed compounding pharmacy. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. There is currently no FDA-approved oral tirzepatide product on the market. FDA-approved tirzepatide is available only as an injection (Mounjaro®, Zepbound®). Your provider may recommend compounded oral tirzepatide where clinically appropriate based on your evaluation.
These statements have not been evaluated by the Food and Drug Administration. Individual results vary. This product is not intended to diagnose, treat, cure, or prevent any disease.
Tirzepatide tablets for weight support
Fitish offers tirzepatide in an oral tablet, an option some people prefer over injections. As part of a provider-prescribed program, tirzepatide supports weight and metabolic goals alongside the everyday habits that keep you feeling good. Your provider helps you find the approach that fits, whether that is a full-dose program or a gentler starting point.
How to get tirzepatide online with Fitish
Getting started with Fitish is simple. You complete a short online health intake, a licensed provider reviews it, and if tirzepatide is a good fit, your prescription is sent to a compounding pharmacy and shipped to your door. No waiting rooms and no in-person visit. You can message your care team any time along the way.
New to GLP-1? Read our guide to weight loss shots and how they work.
Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range. Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider. If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point. A provider will review your intake and recommend the program that fits your goals and health profile.
Want the gentle lane explained? Read our guide to microdosing tirzepatide, or compare starting doses side by side in the GLP-1 microdosing dose chart.
Frequently asked questions
Can I get tirzepatide online?
Yes. With Fitish you complete an online health intake, a licensed provider reviews it, and if appropriate your tirzepatide prescription is filled by a compounding pharmacy and shipped to you.
Do I need a prescription?
Yes. Tirzepatide is prescription-only. A licensed provider reviews your intake and determines whether it is right for you.
Does tirzepatide come in a pill form?
Yes. Fitish RX offers tirzepatide pills as a daily oral tablet, a needle-free alternative to the weekly injection. There is currently no FDA-approved tirzepatide pill; FDA-approved tirzepatide is available only as an injection. Compounded oral tirzepatide is prepared by a state licensed compounding pharmacy and is not FDA-approved.
Is there an FDA-approved oral tirzepatide?
No. There is currently no FDA-approved oral tirzepatide product. FDA-approved tirzepatide is available only as an injection. Compounded oral tirzepatide is prepared by a state licensed compounding pharmacy and is not FDA-approved.
How does tirzepatide support weight goals?
Prescribed as part of a provider-guided program, tirzepatide supports weight and metabolic goals. Your provider tailors the plan to you and adjusts it over time.
How is oral tirzepatide taken?
Once daily, ideally on an empty stomach with a small amount of water. Your provider confirms your dose and timing in your patient portal.
How is it different from the injection?
It uses the same active mechanism in a daily needle-free tablet. Oral tirzepatide may take slightly longer to reach peak effect than the injectable form.
How much does it cost?
$339 for a monthly supply (4 weeks), including your provider consult, the medication if approved, and shipping.
Can I pay with my HSA or FSA?
Sometimes. Some plans and cards will go through and others will not, and that part is largely outside our control. Card networks currently treat compounded telehealth prescriptions inconsistently, so an HSA or FSA card can be declined at checkout even when your plan would otherwise allow the expense. Eligibility is determined by your plan and your plan administrator, not by us. If you want to use those funds, the most reliable route is to check with your administrator first, pay with any other card, and submit for reimbursement. Your provider can issue a Letter of Medical Necessity to support that request.
What are the most common side effects?
Usually mild gastrointestinal symptoms that ease over time. Your provider reviews the full safety profile with you before you begin.
For more detail, see The Clinic FAQ page or our Fitish RX Safety Information. The Black Box warnings, full side effect list, and drug interaction details remain in the Safety Details section below.
More
Tirzepatide is a GLP-1 and GIP receptor agonist medication. Compounded tirzepatide is custom-prepared by a state-licensed compounding pharmacy based on a prescription from a licensed provider. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. State-licensed compounding pharmacies follow both federal and state regulations, including quality standards.
FAQ
- What is oral compounded tirzepatide and how does it work? Oral compounded tirzepatide is a sublingual (dissolving under the tongue) tablet version of tirzepatide compounded by pharmacies; it delivers the same dual GLP‑1/GIP mechanism for appetite control and metabolic support via absorption through the mouth lining.
- Is compounded oral tirzepatide FDA-approved? No — compounded versions aren't FDA-approved and don’t go through the same quality and safety testing as branded versions.
- Can oral compounded tirzepatide help with weight loss? When paired with lifestyle changes, GLP-1/GIP medications are used to support weight management, though individual results vary. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety or effectiveness.
- What dosage forms are available for oral compounded tirzepatide? It typically comes as a once-daily sublingual tablet designed to dissolve under the tongue—absorbing through the mucous membranes rather than being swallowed.
- Why was compounded oral tirzepatide available in the first place? It emerged during brand-name shortages, offering a workaround via compounding pharmacies to meet high demand when commercial supply was limited.
- Are side effects similar to injectable tirzepatide? The side effect profile is similar to injectables and may include nausea, reduced appetite, bloating, or mild gastrointestinal discomfort—though consistency can vary due to compounding differences.
- What dosing is typical for oral compounded tirzepatide? Reported dosing usually ranges from 3–6 mg daily, sometimes starting lower for microdosing protocols, but precise dosing can vary by provider guide.
- Is absorption reliable in oral forms compared to injections? Peptides like tirzepatide are typically broken down in the digestive tract, so sublingual delivery aims to bypass this—but absorption can be less predictable than weekly injectables.
Safety Details
Compounded Tirzepatide (Oral Tablet)
BLACK BOX WARNING: RISK OF THYROID C-CELL TUMORS
Tirzepatide may cause serious side effects, including possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Tirzepatide and medicines that work like Tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if Tirzepatide will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
ABOUT COMPOUNDED MEDICATIONS
Compounded tirzepatide is prepared by a state licensed sterile compounding pharmacy and is prescribed where clinically appropriate based on your medical evaluation. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Your provider determines your dose based on your medical evaluation. FDA-approved medicines containing tirzepatide are commercially available.
Do not use Tirzepatide if:
You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
You have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tirzepatide may cause serious side effects, including:
Inflammation of the pancreas (pancreatitis): Stop using Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
Low blood sugar (hypoglycemia): Your risk for getting low blood sugar may be higher if you use Tirzepatide with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
Serious allergic reactions: Stop using Tirzepatide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
Kidney problems (kidney failure): In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
Severe stomach problems: Stomach problems, sometimes severe, have been reported in people who use Tirzepatide. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Changes in vision: Tell your healthcare provider if you have changes in vision during treatment with Tirzepatide.
Gallbladder problems: Gallbladder problems have happened in some people who use Tirzepatide. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.
SIDE EFFECTS
Many people experience no side effects. Some of the most common or potential side effects of Tirzepatide include:
Nausea
Diarrhea
Decreased Appetite
Vomiting
Constipation
Indigestion
Stomach (Abdominal) Pain
These are not all the possible side effects of Tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
DRUG INTERACTIONS
As with other medications, compounded Tirzepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Tirzepatide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Tirzepatide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (i.e., warfarin) should be monitored closely while on Tirzepatide.
This summary provides basic information about compounded Tirzepatide but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about compounded Tirzepatide and how to take it. Your healthcare provider is the best person to help you decide if compounded Tirzepatide is right for you.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.
You are encouraged to report negative side effects of compounded tirzepatide to the FDA. Visit https://www.fda.gov/medwatch or call 1800FDA1088. In case of emergencies, please call 911 or go to the nearest emergency room.




